Who owns APREA THERAPEUTICS INC?
- Ticker: APRE
- CUSIP Number: 03836j201
Tip: Access positions for across all investors
Analyze quarterly positions in Aprea Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Aprea Therapeutics stock
Who bought or sold APREA THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| AIGH Capital Management | 349k | $1.6M | 0% | Dec 2023 |
|
| Worth Venture Partners | 87k | $410k | 0% | Dec 2023 |
|
| Walleye Trading Advisors | 80k | $376k | -3% | Dec 2023 |
|
| Royal Bank of Canada | 44k | $207k | 13788% | Dec 2023 |
|
| Vanguard Group | 35k | $163k | 27% | Dec 2023 |
|
| Bank of America Corporation | 3.3k | $16k | 0% | Dec 2023 |
|
| Pnc Financial Services | 1.0k | $4.7k | 0% | Dec 2023 |
|
| Wells Fargo & Company | 272.00 | $1.3k | 1% | Dec 2023 |
|
| Advisor Group Holdings | 200.00 | $940.000000 | 0% | Dec 2023 |
|
| WealthCollab | 158.00 | $742.995000 | 100% | Dec 2023 |
|
| Jpmorgan Chase & Co | 5.00 | $24.000000 | 25% | Dec 2023 |
|
| UBS Group | 3.00 | $14.000100 | 0% | Dec 2023 |
|
Who sold out of Aprea Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Creative Planning | Sep 2023 | 25.00 | $105.000000 |